切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2010, Vol. 04 ›› Issue (06) : 655 -660. doi: 10.3877/cma.j.issn.1674-0807.2010.06.006

乳腺癌研究进展专题

青年乳腺癌患者术后妊娠对预后影响的研究进展
赵富东1, 赵玉彪1, 王剑2, 沈坤炜3, 韩宝三3,()   
  1. 1.671000 大理,云南省大理市第一人民医院乳腺外科
    2.264200 威海,山东省威海市妇幼保健院乳腺外科
    3.200025 上海,上海交通大学医学院附属瑞金医院乳腺疾病诊治中心
  • 收稿日期:2010-02-11 出版日期:2010-12-01
  • 通信作者: 韩宝三

Effect of postoperative pregnancy on prognosis in young-age breast cancer patients

Fu-dong ZHAO, Yu-biao ZHAO, Jian WANG, Kun-wei Shen, Bao-san Han()   

  • Received:2010-02-11 Published:2010-12-01
  • Corresponding author: Bao-san Han
引用本文:

赵富东, 赵玉彪, 王剑, 沈坤炜, 韩宝三. 青年乳腺癌患者术后妊娠对预后影响的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(06): 655-660.

Fu-dong ZHAO, Yu-biao ZHAO, Jian WANG, Kun-wei Shen, Bao-san Han. Effect of postoperative pregnancy on prognosis in young-age breast cancer patients[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2010, 04(06): 655-660.

[1]
Thewes B,Meiser B,Taylor A,et al.Fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer.J Clin Oncol,2005,23:5155-5165.
[2]
Duffy CM,Allen SM,Clark MA.Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.J Clin Oncol,2005,23:766-773.
[3]
Partridge AH,Gelber S,Peppercorn J,et al.Web-based survey of fertility issues in young women with breast cancer.J Clin Oncol,2004,22:4174-4183.
[4]
Bines J,Oleske D,Cobleigh M.Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.J Clin Oncol,1996,14:1718-1729.
[5]
Minton SE,Munster PN.Chemotherapy-induced amenorrhoea and fertility in women undergoing adjuvant treatment for breast cancer.Cancer Control,2002,9:466-472.
[6]
Hortobagyi GN,Buzdar AU,Marcus CE,et al.Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at MD Anderson Hospital and Tumor Institute.NCI Monogr,1986,1:105-109.
[7]
Goodwin PJ,Ennis M,Pritchard KI,et al.Risk of menopause during the first year after breast cancer diagnosis.J Clin Oncol,1999,17:2365-2370.
[8]
Parulekar WR,Day AG,Ottaway JA,et al.Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer:analysis of a National Cancer Institute of Canada Clinical Trials Group Study-NCIC CTG MA 5.J Clin Oncol,2005,23:6002-6008.
[9]
Petrek JA,Naughton MJ,Case LD,et al.Incidence,time course,and determinants of menstrual bleeding after breast cancer treatment:a prospective study.J Clin Oncol,2006,24:1045-1051.
[10]
Martin M,Pienkowski T,Mackey J,et al.Adjuvant docetaxel for node-positive breast cancer.N Engl J Med,2005,352:2302-2313.
[11]
Davis AL,Klitus M,Mintzer DM.Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment:the effect of the addition of taxanes.Clin Breast Cancer,2005,6:421-424.
[12]
Kramer R,Tham YL,Sexton K,et al.Chemotherapy-induced amenorrhea is increased in patients treated with adjuvant doxorubicin and cyclophosphamide(AC)followed by a taxane(T):ASCO annual meeting proceedings.J Clin Oncol,2005,23:651.
[13]
Fornier MN,Modi S,Panageas KS,et al.Incidence of chemotherapy-induced,long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.Cancer,2005,104:1575-1579.
[14]
Mueller BA,Simon MS,Deapen D,et al.Childbearing and survival after breast carcinoma in young women.Cancer,2003,98:1131-1140.
[15]
Kroman N,Jensen MB,Wohlfahrt J,et al.Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.Acta Oncol,2008,47:545-549.
[16]
Ives A,Saunders C,Bulsara M,et al.Pregnancy after breast cancer:population based study.BMJ,2007,334:194-196.
[17]
Sankila R,Heinavaara S,Hakulinen T.Survival of breast cancer patients after subsequent term pregnancy:“healthy mother effect”.Am J Obstet Gynecol,1994,170:818-823.
[18]
von Schoultz E,Johansson H,Wilking N,et al.Influence of prior and subsequent pregnancy on breast cancer prognosis.J Clin Oncol,1995,13:430-434.
[19]
Velentgas P,Daling JR,Malone KE,et al.Pregnancy after breast carcinoma:outcomes and influence on mortality.Cancer,1999,85:2424-2432.
[20]
Gelber S,Coates AS,Goldhirsch A,et al.Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.J Clin Onco,2001,19:1671-1675.
[21]
Blakely LJ,Buzdar AU,Lozada JA,et al.Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.Cancer,2004,100:465-469.
[22]
Hawkins MM.Pregnancy outcome and offspring after childhood cancer.BMJ,1994,309:1034.
[23]
Lambe M,Hsieh C,Trichopoulos D,et al.Transient increase in the risk of breast cancer after giving birth.N Engl J Med,1994,331:5-9.
[24]
Hsieh C,Pavia M,Lambe M,et al.Dual effect of parity on breast cancer risk.Eur J Cancer,1994,30A:969-973.
[25]
Leon DA,Carpenter LM,Broeders MJ,et al.Breast cancer in Swedish women before age 50:evidence of a dual effect of completed pregnancy.Cancer Causes Control,1995,6:283-291.
[26]
Russo J,Moral R,Balogh GA,et al.The protective role of pregnancy in breast cancer.Breast Cancer Res,2005,7:131-142.
[27]
Russo J,Russo IH.The etiopathogenesis of breast cancer prevention.Cancer Lett,1995,90:81-89.
[28]
D'Cruz CM,Moody SE,Master SR,et al.Persistent parity-induced changes in growth factors,TGF-beta3,and differentiation in the rodent mammary gland.Mol Endocrinol,2002,16:2034-2051.
[29]
Booth D,Haley JD,Bruskin AM,et al.Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation,possibly by reducing stem-cell cycling.Int J Cancer,2000,86:53-59.
[30]
Dao MA,Hwa J,Nolta JA.Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+)progenitors.Blood,2002,99:499-506.
[31]
Sakariassen PO,Immervoll H,Chekenya M.Cancer stem cells as mediators of treatment resistance in brain tumors:status and controversies.Neoplasia,2007,9:882-892.
[32]
Tang C,Chua CL,Ang BT.Insights into the cancer stem cell model of glioma tumorigenesis.Ann Acad Med Singapore,2007,36:352-357.
[33]
Yuri T,Tsukamoto R,Miki K,et al.Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells.Oncol Rep,2006,16:1307-1312.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[8] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[11] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[12] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[13] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要